| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/04/2023 | -2.97% | Wells Fargo | $20 → $17 | Maintains | Equal-Weight |
| 07/31/2023 | 14.16% | Goldman Sachs | $18 → $20 | Maintains | Sell |
| 06/29/2023 | 25.57% | JP Morgan | $20 → $22 | Maintains | Neutral |
| 05/01/2023 | 19.86% | Piper Sandler | $22 → $21 | Maintains | Neutral |
| 05/01/2023 | 36.99% | Keefe, Bruyette & Woods | $26 → $24 | Maintains | Market Perform |
| 04/06/2023 | 48.4% | Keefe, Bruyette & Woods | $32 → $26 | Maintains | Market Perform |
| 04/05/2023 | 48.4% | Wells Fargo | $28 → $26 | Maintains | Equal-Weight |
| 03/30/2023 | 25.57% | Goldman Sachs | $27 → $22 | Maintains | Sell |
| 01/30/2023 | 59.82% | Wells Fargo | $26 → $28 | Maintains | Equal-Weight |
| 12/13/2022 | 48.4% | JP Morgan | → $26 | Upgrades | Underweight → Neutral |
| 04/25/2022 | 94.06% | Keefe, Bruyette & Woods | → $34 | Downgrades | Outperform → Market Perform |
| 04/25/2022 | 48.4% | Wells Fargo | $28 → $26 | Maintains | Equal-Weight |
| 03/21/2022 | 59.82% | Wells Fargo | $26 → $28 | Maintains | Equal-Weight |
| 01/24/2022 | 65.53% | Compass Point | $32 → $29 | Downgrades | Buy → Neutral |
| 01/04/2022 | 48.4% | Wells Fargo | $28 → $26 | Maintains | Equal-Weight |
| 10/08/2021 | 88.36% | B of A Securities | → $33 | Downgrades | Neutral → Underperform |
| 07/08/2021 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 07/01/2021 | 59.82% | Wells Fargo | → $28 | Upgrades | Underweight → Equal-Weight |
| 05/13/2021 | 59.82% | UBS | $22 → $28 | Upgrades | Sell → Neutral |
| 10/26/2020 | 8.45% | Piper Sandler | $16 → $19 | Maintains | Neutral |
| 10/01/2020 | -8.68% | Piper Sandler | $18 → $16 | Maintains | Neutral |
| 07/07/2020 | -25.8% | Wells Fargo | $16 → $13 | Downgrades | Equal-Weight → Underweight |
| 06/29/2020 | -25.8% | UBS | $15 → $13 | Downgrades | Neutral → Sell |
| 06/08/2020 | 31.28% | B of A Securities | $19 → $23 | Upgrades | Neutral → Buy |
| 05/15/2020 | -14.38% | UBS | $14.5 → $15 | Maintains | Neutral |
| 03/30/2020 | -8.68% | Wells Fargo | $26 → $16 | Maintains | Equal-Weight |
| 03/04/2020 | 42.69% | Compass Point | $33 → $25 | Downgrades | Buy → Neutral |
| 12/19/2019 | — | Piper Sandler | Initiates Coverage On | → Hold | |
| 07/29/2019 | 48.4% | JP Morgan | $26.5 → $26 | Downgrades | Neutral → Underweight |
| 10/29/2018 | 48.4% | Citigroup | $32 → $26 | Maintains | Neutral |
What is the target price for First Hawaiian (FHB)?
The latest price target for First Hawaiian (NASDAQ: FHB) was reported by Wells Fargo on October 4, 2023. The analyst firm set a price target for $17.00 expecting FHB to fall to within 12 months (a possible -2.97% downside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for First Hawaiian (FHB)?
The latest analyst rating for First Hawaiian (NASDAQ: FHB) was provided by Wells Fargo, and First Hawaiian maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for First Hawaiian (FHB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of First Hawaiian, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for First Hawaiian was filed on October 4, 2023 so you should expect the next rating to be made available sometime around October 4, 2024.
Is the Analyst Rating First Hawaiian (FHB) correct?
While ratings are subjective and will change, the latest First Hawaiian (FHB) rating was a maintained with a price target of $20.00 to $17.00. The current price First Hawaiian (FHB) is trading at is $17.52, which is out of the analyst's predicted range.